Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.
2.

Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.

Ponti G, Losi L, Di Gregorio C, Roncucci L, Pedroni M, Scarselli A, Benatti P, Seidenari S, Pellacani G, Lembo L, Rossi G, Marino M, Lucci-Cordisco E, Ponz de Leon M.

Cancer. 2005 Mar 1;103(5):1018-25.

3.
4.

Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population.

Archer-Dubon C, Alvarez-Zavala B, Reyes E, Orozco-Topete R.

Dermatol Online J. 2008 Dec 15;14(12):1.

5.

Muir-Torre syndrome.

Ponti G, Ponz de Leon M.

Lancet Oncol. 2005 Dec;6(12):980-7. Review.

PMID:
16321766
6.

Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test.

Mathiak M, Rütten A, Mangold E, Fischer HP, Ruzicka T, Friedl W, Propping P, Kruse R.

Am J Surg Pathol. 2002 Mar;26(3):338-43.

PMID:
11859205
7.

Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.

Abbas O, Mahalingam M.

J Cutan Pathol. 2009 Jun;36(6):613-9. doi: 10.1111/j.1600-0560.2009.01248.x. Review.

PMID:
19515040
8.

[Muir-Torre syndrome: rare association with duodenal carcinoma].

Bacha D, Deschamps L, Sauvanet A, Couvelard A.

Ann Pathol. 2009 Dec;29(6):495-8. doi: 10.1016/j.annpat.2009.10.021. Epub . French.

PMID:
20005439
9.

Muir-Torre syndrome: role of the dermatopathologist in diagnosis.

Curry ML, Eng W, Lund K, Paek D, Cockerell CJ.

Am J Dermatopathol. 2004 Jun;26(3):217-21.

PMID:
15166510
10.

The significance of DNA mismatch repair genes in the diagnosis and management of periocular sebaceous cell carcinoma and Muir-Torre syndrome.

Gaskin BJ, Fernando BS, Sullivan CA, Whitehead K, Sullivan TJ.

Br J Ophthalmol. 2011 Dec;95(12):1686-90. doi: 10.1136/bjophthalmol-2011-300612. Epub 2011 Oct 6.

PMID:
21979897
11.

Different phenotypes in Muir-Torre syndrome: clinical and biomolecular characterization in two Italian families.

Ponti G, Ponz de Leon M, Losi L, Di Gregorio C, Benatti P, Pedroni M, Scarselli A, Riegler G, Lembo L, Pellacani G, Seidenari S, Rossi G, Roncucci L.

Br J Dermatol. 2005 Jun;152(6):1335-8. Review.

PMID:
15949004
12.

[Female patient with Muir-Torre syndrome].

Negraszus N, Jöhrens K, Bertelmann E.

Ophthalmologe. 2010 Nov;107(11):1059-62. doi: 10.1007/s00347-010-2165-0. German.

PMID:
20393721
13.

[Muir-Torre syndrome. An interdisciplinary challenge].

Anders D, Kneitz H, Kunstmann E, Bröcker EB, Benoit S.

Hautarzt. 2012 Mar;63(3):226-9. doi: 10.1007/s00105-011-2213-y. German.

PMID:
21858561
14.

MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir-Torre syndrome.

Chhibber V, Dresser K, Mahalingam M.

Mod Pathol. 2008 Feb;21(2):159-64. Epub 2007 Dec 7.

15.

Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome.

Machin P, Catasus L, Pons C, Muñoz J, Conde-Zurita JM, Balmaña J, Barnadas M, Martí RM, Prat J, Matias-Guiu X.

J Cutan Pathol. 2002 Aug;29(7):415-20.

PMID:
12139636
16.

Biallelic MYH germline mutations as cause of Muir-Torre syndrome.

Guillén-Ponce C, Castillejo A, Barberá VM, Pascual-Ramírez JC, Andrada E, Castillejo MI, Guarinós C, Molina-Garrido MJ, Carrato A, Soto JL.

Fam Cancer. 2010 Jun;9(2):151-4. doi: 10.1007/s10689-009-9309-x.

PMID:
19998059
17.

Molecular pathologic analysis enhances the diagnosis and management of Muir-Torre syndrome and gives insight into its underlying molecular pathogenesis.

Southey MC, Young MA, Whitty J, Mifsud S, Keilar M, Mead L, Trute L, Aittomäki K, McLachlan SA, Debinski H, Venter DJ, Armes JE.

Am J Surg Pathol. 2001 Jul;25(7):936-41.

PMID:
11420466
18.

Muir-Torre syndrome: clinical features and molecular genetic analysis.

Esche C, Kruse R, Lamberti C, Friedl W, Propping P, Lehmann P, Ruzicka T.

Br J Dermatol. 1997 Jun;136(6):913-7.

PMID:
9217825
19.

Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome.

Entius MM, Keller JJ, Drillenburg P, Kuypers KC, Giardiello FM, Offerhaus GJ.

Clin Cancer Res. 2000 May;6(5):1784-9.

20.

[Muir-Torre syndrome and familial colorectal cancer: 2 families with molecular genetic analysis].

Doré MX, Dieumegard B, Grandjouan S, Avril MF, Martinet C, Ducreux M, Lasser P, Bressac-de Paillerets B.

Ann Dermatol Venereol. 1999 Aug-Sep;126(8-9):582-6. French.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk